Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCB01A in Recurrent or Metastatic Head and Neck Cancer
NCT03020823Phase 2Terminated
- Sponsor
- SynCore Biotechnology
- Start
- Apr 2017
- Primary completion
- Nov 2018
- Modality
- Allosteric Modulators, Orthosteric Ligands, PROTACs (E3 ligase recruitment)
- Countries
- 1
01
Overview
A Phase 2 trial of SCB01A in head and neck squamous cell carcinoma (HNSCC), sponsored by SynCore Biotechnology. Started Apr 2017; status: terminated.
02
Drugs
SCB01A
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03020823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020823.